{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:16:35Z","timestamp":1761513395571,"version":"3.44.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Clinical Epidemiology of the Leiden University Medical Center, Leiden, The Netherlands"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.thromres.2013.12.041","type":"journal-article","created":{"date-parts":[[2014,1,6]],"date-time":"2014-01-06T21:00:31Z","timestamp":1389042031000},"page":"640-644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives"],"prefix":"10.1016","volume":"133","author":[{"given":"M.","family":"Raps","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Curvers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.M.","family":"Helmerhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.E.P.B.","family":"Ballieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rosing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Thomassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.R.","family":"Rosendaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.A.A.M.","family":"van Vliet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.thromres.2013.12.041_bb0005","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Eng J Med"},{"key":"10.1016\/j.thromres.2013.12.041_bb0010","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case\u2013control study","volume":"339","author":"Van Hylckama","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2013.12.041_bb0015","first-page":"1","article-title":"Cardiovascular disease and steroid hormone contraception","volume":"877[i-vii]","year":"2011"},{"issue":"7","key":"10.1016\/j.thromres.2013.12.041_bb0020","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1538-7836.2003.00264.x","article-title":"Estrogens, progestogens and thrombosis","volume":"1","author":"Rosendaal","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"8990","key":"10.1016\/j.thromres.2013.12.041_bb0025","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"issue":"8990","key":"10.1016\/j.thromres.2013.12.041_bb0030","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2013.12.041_bb0035","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"issue":"8990","key":"10.1016\/j.thromres.2013.12.041_bb0040","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2013.12.041_bb0045","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case\u2013control study based on UK General Practice Research Database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2013.12.041_bb0050","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case\u2013control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"BMJ"},{"issue":"18","key":"10.1016\/j.thromres.2013.12.041_bb0055","doi-asserted-by":"crossref","first-page":"E1319","DOI":"10.1503\/cmaj.110463","article-title":"Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study","volume":"183","author":"Gronich","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.thromres.2013.12.041_bb0060","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2013.12.041_bb0070","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001\u201310","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.thromres.2013.12.041_bb0075","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"Van Hylckama","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9195","key":"10.1016\/j.thromres.2013.12.041_bb0080","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.thromres.2013.12.041_bb0085","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/j.1538-7836.2004.00983.x","article-title":"Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate","volume":"2","author":"Van Vliet","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.thromres.2013.12.041_bb0090","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1160\/TH07-07-0439","article-title":"Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography","volume":"98","author":"Tchaikovski","year":"2007","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.thromres.2013.12.041_bb0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2141.2003.04443.x","article-title":"Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women","volume":"122","author":"Tans","year":"2003","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.thromres.2013.12.041_bb0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-7824(02)00436-5","article-title":"Effect of four different oral contraceptives on various sex hormones and serum-binding globulins","volume":"67","author":"Wiegratz","year":"2003","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.thromres.2013.12.041_bb0105","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.contraception.2008.02.005","article-title":"Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use","volume":"77","author":"S\u00e4nger","year":"2008","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.thromres.2013.12.041_bb0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0010-7824(93)90109-K","article-title":"The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters","volume":"47","author":"Kuhl","year":"1993","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.thromres.2013.12.041_bb0115","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/13625187.2011.614363","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17beta-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function","volume":"16","author":"\u00c5gren","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"10.1016\/j.thromres.2013.12.041_bb0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.contraception.2006.04.005","article-title":"Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins","volume":"74","author":"White","year":"2006","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.thromres.2013.12.041_bb0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13625180400007199","article-title":"A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function","volume":"9","author":"Duijkers","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"10.1016\/j.thromres.2013.12.041_bb0130","first-page":"482","article-title":"Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?","volume":"81","author":"Odlind","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.thromres.2013.12.041_bb0135","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2008.11.002","article-title":"Sex hormone-binding globulin: an adequate surrigate marker for venous thromboembolism in women using new hormonal contraceptives","volume":"79","author":"Van Vliet","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2013.12.041_bb0140","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1538-7836.2012.04720.x","article-title":"Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives","volume":"10","author":"Raps","year":"2012","journal-title":"J Thromb Haemostasis"},{"author":"European Medicines Agency","key":"10.1016\/j.thromres.2013.12.041_bb0145"},{"issue":"12","key":"10.1016\/j.thromres.2013.12.041_bb0150","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1538-7836.2010.04054.x","article-title":"The effect of changes in thyroxine and thyroid-stimulating hormone levels on the coagulation system","volume":"8","author":"Debeij","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.thromres.2013.12.041_bb0155","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1538-7836.2012.04818.x","article-title":"Increased levels of free thyroxine and risk of venous thrombosis in a large population-based prospective study","volume":"10","author":"Debeij","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"22","key":"10.1016\/j.thromres.2013.12.041_bb0160","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1182\/blood-2009-11-253724","article-title":"Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case\u2013control study","volume":"115","author":"Van Zaane","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2013.12.041_bb0165","first-page":"1077","article-title":"The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors. A systematic review and meta-analysis","volume":"108","author":"Stuijver","year":"2012","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.thromres.2013.12.041_bb0170","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1538-7836.2011.04430.x","article-title":"Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study","volume":"9","author":"Van Zaane","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.thromres.2013.12.041_bb0175","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.thromres.2008.04.022","article-title":"Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study","volume":"123","author":"Fleischer","year":"2009","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.thromres.2013.12.041_bb0180","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1160\/TH08-09-0621","article-title":"The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC)","volume":"101","author":"Van Vliet","year":"2009","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.thromres.2013.12.041_bb0185","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.thromres.2007.08.010","article-title":"Sensitivity to activated protein C during the menstrual cycle in women with and without factor VLeiden","volume":"121","author":"Van Vliet","year":"2008","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.thromres.2013.12.041_bb0190","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0010-7824(03)00006-4","article-title":"Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters","volume":"67","author":"Wiegratz","year":"2003","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.thromres.2013.12.041_bb0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2013.12.041_bb0200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2003-38334","article-title":"Venous and arterial thrombosis during oral contraceptive use: risks and risk factors","volume":"3","author":"Tanis","year":"2003","journal-title":"Semin Vasc Med"},{"issue":"3","key":"10.1016\/j.thromres.2013.12.041_bb0205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0010-7824(98)00020-1","article-title":"Blood coagulation and oral contraceptives. A critical review","volume":"57","author":"Winkler","year":"1998","journal-title":"Contraception"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2013.12.041_bb0210","first-page":"81","article-title":"Mechanisms of OC related thrombosis","volume":"115","author":"Rosing","year":"2005","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.thromres.2013.12.041_bb0215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1657546","article-title":"Effect of oral contraceptives on haemostasis variables","volume":"78","author":"Kluft","year":"1997","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.thromres.2013.12.041_bb0220","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/humrep\/deh612","article-title":"Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens","volume":"20","author":"Van Vliet","year":"2005","journal-title":"Hum Reprod"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481400005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481400005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:36:54Z","timestamp":1758735414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938481400005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S004938481400005X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.12.041","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}